PTGS2 and neoplasm: This substance produces inhibition of tissue polypeptide antigen (TPA), a tumor inducer driven by exposure to ultraviolet B (UVB) radiation, and a reduction in the concentration of COX-2, PGE1, and EP1 and EP2 receptors [37].